Since we showed that PLD2 overexpression leads to an increase in CSC-like cells in OC and CSCs were previously proposed to be responsible for chemotherapy resistance and tumor relapse, we wondered whether PLD2 overexpression could cause resistance to conventional therapy in ovarian tumors. This evidence concerns the gene PLD2 and ovarian neoplasm.